WSM insider files to sell 75,000 shares worth $12.6M under Form 144

Q: How many Williams-Sonoma (WSM) shares are proposed for sale in this Form 144?

75,000 common shares are scheduled for sale on 15 July 2025.

Q: What is the estimated market value of the WSM shares to be sold?

The aggregate market value is US$12,610,695.50 based on prices at the time of filing.

Q: Who executed recent insider sales of Williams-Sonoma stock?

Laura Alber sold 30,000 shares on 29 May 2025, generating US$4.93 million in gross proceeds.

Q: How significant is the planned sale relative to WSM鈥檚 shares outstanding?

It represents approximately 0.06 % of the 122,998,061 shares outstanding.

Q: On which exchange will the shares be sold and through which broker?

The sale is slated for the NYSE via Merrill , 555 California St., San Francisco.

[Form 4] Gilead Sciences Inc Insider Trading Activity

Filing Impact

(Moderate)

Filing Sentiment

(Negative)

Form Type

Rhea-AI Filing Summary

Williams-Sonoma, Inc. (WSM) has filed a Form 144 indicating the planned sale of insider shares under Rule 144.

Shares to be sold: 75,000 common shares
Estimated value: US$12,610,695.50 (based on the market price at filing)
Broker: Merrill, 555 California St., San Francisco, CA 94103
Planned sale date: 15 July 2025 on the NYSE
Shares outstanding: 122,998,061, so the proposed sale equals roughly 0.06 % of shares outstanding
Source of shares: 165,000 RSUs acquired on 16 April 2024 for cash consideration
Recent insider activity: Laura Alber sold 30,000 shares on 29 May 2025 for gross proceeds of US$4,929,685.47

The filing provides notice that the seller (not expressly named for the current transaction, but Laura Alber is listed as the most recent seller) does not possess undisclosed material adverse information, a standard representation under Rule 144. No financial performance data or earnings metrics are included; the document is limited to insider sale disclosures.

Positive

Regulatory transparency: The Form 144 gives timely notice of insider intent, reducing information asymmetry for investors.

Negative

Insider selling pressure: Planned sale of 75,000 shares plus 30,000 already sold may be interpreted as reduced management confidence, albeit economically small.

Insights

TL;DR: Insider plans to sell ~US$12.6 m in stock鈥攕mall relative to float, signal largely neutral.

Rule 144 filings are routine for executives liquidating vested equity. The 75,000-share block equates to only 0.06 % of WSM鈥檚 outstanding shares, which limits market impact. Combined with the 30,000 shares sold in May, total insider dispositions over three months reach ~US$17.6 m, still immaterial against WSM鈥檚 multi-billion-dollar market cap. No adverse information is asserted, and the sale may be under a 10b5-1 plan. I view the disclosure as neutral to the investment thesis, though investors may monitor for persistent selling trends.

TL;DR: Consecutive insider sales could raise governance-watcher eyebrows; modestly negative sentiment.

Frequent executive sales can trigger perception risks, especially when clustered. While the percentage is small, the cumulative 105,000 shares filed/sold within a short window suggests the executive is tightening personal exposure ahead of FY26. The absence of any mention of a pre-arranged 10b5-1 plan in the signature section (date left blank) may heighten scrutiny. From a governance lens, this is a modest negative even if economically de minimis.

07/15/2025 - 03:59 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Bluestone Jeffrey

(Last)

(First)

(Middle)

333 LAKESIDE DRIVE

(Street)

FOSTER CITY

94404

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
GILEAD SCIENCES, INC. [ GILD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
07/14/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	07/14/2025		M⁽¹⁾		5,000	A	$67.45	13,920	D
Common Stock	07/14/2025		S⁽¹⁾		5,000	D	$109.74	8,920	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Non-qualified Stock Option (Right to Buy)	$67.45	07/14/2025		M⁽¹⁾			5,000	⁽²⁾	05/12/2031	Common Stock	5,000	$0	9,665	D

Explanation of Responses:

1. The transactions reported on this Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on February 13, 2025.

2. 25% of the shares subject to the option vest on each three-month anniversary from May 12, 2021 such that 100% of the shares subject to the option will be fully vested and exercisable upon the earlier of May 12, 2022 or the day immediately preceding the next regular annual stockholders meeting.

	/s/ Edward S. Son by Power of Attorney for Jeffrey A. Bluestone	07/15/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source:

FAQ

How many Williams-Sonoma (WSM) shares are proposed for sale in this Form 144?

75,000 common shares are scheduled for sale on 15 July 2025.

What is the estimated market value of the WSM shares to be sold?

The aggregate market value is US$12,610,695.50 based on prices at the time of filing.

Who executed recent insider sales of Williams-Sonoma stock?

Laura Alber sold 30,000 shares on 29 May 2025, generating US$4.93 million in gross proceeds.

How significant is the planned sale relative to WSM鈥檚 shares outstanding?

It represents approximately 0.06 % of the 122,998,061 shares outstanding.

On which exchange will the shares be sold and through which broker?

The sale is slated for the NYSE via Merrill, 555 California St., San Francisco.

AG真人官方

[Form 4] Gilead Sciences Inc Insider Trading Activity

Insights

FAQ

How many Williams-Sonoma (WSM) shares are proposed for sale in this Form 144?

What is the estimated market value of the WSM shares to be sold?

Who executed recent insider sales of Williams-Sonoma stock?

How significant is the planned sale relative to WSM鈥檚 shares outstanding?

On which exchange will the shares be sold and through which broker?

NASDAQ:GILD

GILD Rankings

GILD Latest News

GILD Latest SEC Filings

GILD Stock Data

AG真人官方

Trending News

[Form 4] Gilead Sciences Inc Insider Trading Activity

Insights

Securities Analyst neutral

Corporate Governance Expert negative

FAQ

How many Williams-Sonoma (WSM) shares are proposed for sale in this Form 144?

What is the estimated market value of the WSM shares to be sold?

Who executed recent insider sales of Williams-Sonoma stock?

How significant is the planned sale relative to WSM鈥檚 shares outstanding?

On which exchange will the shares be sold and through which broker?

NASDAQ:GILD

GILD Rankings

GILD Latest News

GILD Latest SEC Filings

GILD Stock Data